These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 582992)

  • 1. [The pharmacology of 1-propyl-3-methyl-7-(5-hydroxyhexyl) xanthine (HWA 153), a new bronchodilatory xanthine derivative].
    Anagnostopoulos C; Komarek J
    Arzneimittelforschung; 1979; 29(7):1013-24. PubMed ID: 582992
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental studies on the antitussive properties of the new xanthine derivative 1H-purine-2,6-dione, 3,7-dihydro-3-methyl-7[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]. 2nd communication: investigations on theophylline-like activities.
    Mikus EG; Kapui Z; Korbonits D; Boér K; Boronkay E; Gyürky J; Révész J; Lacheretz F; Pascal M; Arányi P
    Arzneimittelforschung; 1997 Dec; 47(12):1358-63. PubMed ID: 9450164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influence of phosphorylation on the properteis of biological active compounds (author's transl)].
    Chabrier P; Thuong NT; Warolin C; Foussard-Blanpin O; Bretaudeau J; Narcisse G
    Ann Pharm Fr; 1978; 36(7-8):341-8. PubMed ID: 742811
    [No Abstract]   [Full Text] [Related]  

  • 4. General pharmacology of amitriptylinoxide.
    Leuschner F; Neumann W; Doppelfeld IS; Erdös A; Fontaine R; Gabbar HA; Graf E
    Arzneimittelforschung; 1978; 28(10b):1883-93. PubMed ID: 38803
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacodynamic profile of isbufylline, a new antibronchospastic xanthine devoid of central excitatory actions.
    Manzini S; Meini S; Giachetti A; Beani L; Borea PA; Antonelli T; Ballati L; Bacciarelli C
    Arzneimittelforschung; 1990 Nov; 40(11):1205-13. PubMed ID: 1707621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological and toxicological studies of an original xanthine derivative with bronchodilatating activity.
    Staneva D; Chakurova L; Ivanova N; Spasov V; Raynova L; Bogoslovova T
    Acta Physiol Pharmacol Bulg; 1984; 10(4):44-52. PubMed ID: 6535369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the biochemical mechanism of action of 1-propyl-3-methyl-7-(5-hydroxy-hexyl)-xanthine (HWA 153), a new bronchospasmolytically active methyl xanthine derivative.
    Stefanovich V; Porsche E
    Arzneimittelforschung; 1979; 29(6):917-20. PubMed ID: 226104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Compound with bronchospasmolytical activity from the chemical class of beta-phenylethyl-aminoalkyl-xanthines (author's transl)].
    Habersang S; Leuschner F; Stroman F; Domenico A; Schlichtegroll A
    Arzneimittelforschung; 1977; 27(12):22-35. PubMed ID: 15572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological properties of a new antiasthmatic xanthine derivative devoid of central stimulatory activity.
    Duhault J; Boulanger M; Lonchampt M; Tisserand F; Holstorp S; Saint-Romas G; Pennel L; Regnier G
    Arzneimittelforschung; 1987 Dec; 37(12):1353-62. PubMed ID: 2835053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Researches on pharmacological properties of some new xanthine derivatives].
    Dănilă G; Profire L; Costuleanu M
    Rev Med Chir Soc Med Nat Iasi; 2000; 104(4):131-6. PubMed ID: 12089941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacodynamic study of a new antiasthmatic drug. Salbutamol].
    Foussard-Blanpin O; Narcisse G
    Therapie; 1971; 26(6):1081-96. PubMed ID: 4401716
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experimental research on the anti-asthmatic action of morpholino-methyl-theophylline].
    Vertua R; Caffau S
    Clin Ter; 1967 Sep; 42(5):407-19. PubMed ID: 4389841
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacodynamic profile of the new potent antibronchospastic agent 7-[(2,2-dimethyl)propyl]-1-methyl xanthine.
    Evangelista S; Ballati L; Boni P; Castellucci A; Perretti F; Tramontana M; Toja E
    Arzneimittelforschung; 1995 May; 45(5):569-75. PubMed ID: 7612055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological researches on 2-(7'-theophyllinemethyl)1,3-dioxolane.
    Franzone JS; Reboani C; Fonzo D; Di Carlo R
    Farmaco Sci; 1981 Mar; 36(3):201-19. PubMed ID: 6262105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new class of antibronchospastic agents: 7-(2,2-dimethyl)propyl substituted xanthines.
    Bonacchi G; Agostini O; Di Marco G; Borgianni M; Ballati L; Boni P; Castellucci A; Evangelista S; Toja E
    Farmaco; 1995 May; 50(5):333-9. PubMed ID: 7626168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Xanthine derivative compounds potential activity in inflammatory process].
    Dănilă G; Profire L; Costuleanu M
    Rev Med Chir Soc Med Nat Iasi; 2002; 107(2):391-6. PubMed ID: 12638299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cellular anaphylaxis by beta-stimulants.
    Martin LE
    Postgrad Med J; 1971 Mar; 47():Suppl:26-30. PubMed ID: 4102079
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological studies of trans-6-hydroxy-5-hydroxymethyl-2-isopropylamino-1,2,3,4,-tetrahydro-1-naphthalenol hydrochloride (AA-497), a new potent bronchodilator.
    Inatomi N; Kuriki H; Kanno M; Kawazoe K; Nagawa Y; Miyata T; Takahama K; Kasé Y
    Arzneimittelforschung; 1980; 30(2):276-85. PubMed ID: 7378107
    [No Abstract]   [Full Text] [Related]  

  • 19. Design, synthesis and bronchodilatory activity of a series of quinazoline-3-oxides.
    Combs DW; Rampulla MS; Russell RK; Rampulla RA; Klaubert DH; Ritchie D; Meeks AS; Kirchner T
    Drug Des Deliv; 1990 Oct; 6(4):241-54. PubMed ID: 2083028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The profile of action of enprofylline, or why adenosine antagonism seems less desirable with xanthine antiasthmatics.
    Persson CG
    Agents Actions Suppl; 1983; 13():115-29. PubMed ID: 6346831
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.